The Impact of Probiotic Supplementation on General Well Being
1 other identifier
interventional
173
1 country
1
Brief Summary
The health and wellbeing of any workforce is a core priority and taking steps to ensure the wellbeing of employees is an important part of everyday working life. Winter is a time of particular challenge and is linked to increased absenteeism. There is a growing awareness that probiotics (similar to the bacteria found in yogurts) can play a role in boosting general wellbeing. Probiotics are known as 'good' or 'friendly' bacteria and are living organisms that are found naturally in yogurt and fermented foods. They can be capsules, tablets or powders in sachets that are taken daily to help to keep the gut in peak condition. Everyone has trillions of bacteria in their guts living together happily and they are needed to boost our wellbeing but the stresses and strains of everyday life can often disturb their balance, probiotics can help to restore the balance. Over the winter of 2022, a small exploratory study with employees based in South Wales who were offered the opportunity to 'try out' a probiotic manufactured by Cultech Limited (a company based in Port Talbot specialising in the production of nutritional supplements). The results were very promising with significant improvements in wellbeing and reduced absenteeism among those who opted to take the product. This project is designed as a follow-up on last year's exploratory study to further assess effectiveness of the same probiotic nutritional supplement over the winter
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedStudy Start
First participant enrolled
September 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2025
CompletedApril 20, 2025
April 1, 2025
7 months
July 12, 2023
April 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of Life changes
Weekly questionnaires via an app containing questions relating to the participant's quality of life (i.e. mood, sleep, energy levels) over a week period
60 days
Change in Absenteeism
Weekly questionnaires via an app relating to any absences from work over a week period
60 days
Changes in gut symptoms and overall health
Weekly questionnaires via an app containing questions on the number of days participants may have experiences gut related symptoms (i.e. bloating, constipation, diarrhoea, stomach pain), and overall health (i.e. headaches, coughs, sore thorat)
60 days
Secondary Outcomes (1)
Feasibility of app-based probiotic studies
60 days
Study Arms (1)
Active group
EXPERIMENTALInterventions
Multi-strain Probiotic Product: Lactobacillus acidophilus CUL-60, Lactobacillus acidophilus CUL-21, Lactobacillus plantarum CUL-66, Bifidobacterium bifidum CUL-20, Bifidobacterium animalis subsp lactis CUL-34 (total 50 billion bacteria), Vitamin D (400 IU), Vitamin C (80 mg) \& Zinc (10 mg)
Eligibility Criteria
You may qualify if:
- Aged 18 - 60 (at the time of consent)
- Working in an NHS healthcare setting
- Willing to use the Trialflare app on personal phone to record data securely
- Able to understand and communicate using the English language
- Normal or corrected to normal vision 6 Happy to take no other probiotics during study
- \. Able to continue with normal lifestyle throughout 8. Able to consent to take part in the study
You may not qualify if:
- Immunodeficient
- Taking probiotics or have taken within the last month
- Allergic or suspected allergy to zinc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cwm Taf University Health Board (NHS)lead
- Welsh Ambulance Service NHS Trustcollaborator
- Cultech Ltdcollaborator
Study Sites (1)
Cwm Taf Morgannwg Health Board
Pontypridd, Mid Glamorgan, CF37 4AL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2023
First Posted
August 1, 2023
Study Start
September 16, 2024
Primary Completion
April 15, 2025
Study Completion
April 15, 2025
Last Updated
April 20, 2025
Record last verified: 2025-04